
|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Country Report: Belgiumabout 13 years ago
On-Market Pricing Strategiesabout 13 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?about 13 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphabout 13 years ago
Pfizer's Quality by Design Approach to Trial Managementabout 13 years ago
Woman of the Year 2013about 13 years ago
Key to Brand Positioning: Look Inside Your Heartabout 13 years ago
Full Disclosure for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
5




